228 related articles for article (PubMed ID: 15126346)
41. Functional cooperation of Ogg1 and Mutyh in preventing G: C-->T: a transversions in mice.
Isogawa A
Fukuoka Igaku Zasshi; 2004 Jan; 95(1):17-30. PubMed ID: 15031996
[TBL] [Abstract][Full Text] [Related]
42. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
43. DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis.
Claij N; van der Wal A; Dekker M; Jansen L; te Riele H
Cancer Res; 2003 May; 63(9):2062-6. PubMed ID: 12727820
[TBL] [Abstract][Full Text] [Related]
44. Mutational specificity of mice defective in the MTH1 and/or the MSH2 genes.
Egashira A; Yamauchi K; Yoshiyama K; Kawate H; Katsuki M; Sekiguchi M; Sugimachi K; Maki H; Tsuzuki T
DNA Repair (Amst); 2002 Nov; 1(11):881-93. PubMed ID: 12531017
[TBL] [Abstract][Full Text] [Related]
45. High frequency of codon 61 K-ras A-->T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene.
Sills RC; Hong HL; Melnick RL; Boorman GA; Devereux TR
Carcinogenesis; 1999 Apr; 20(4):657-62. PubMed ID: 10223196
[TBL] [Abstract][Full Text] [Related]
46. Thymic lymphomas arising in Msh2 deficient mice display a large increase in mutation frequency and an altered mutational spectrum.
Zhang S; Lloyd R; Bowden G; Glickman BW; de Boer JG
Mutat Res; 2002 Mar; 500(1-2):67-74. PubMed ID: 11890935
[TBL] [Abstract][Full Text] [Related]
47. Analysis of the oxidative damage repair genes NUDT1, OGG1, and MUTYH in patients from mismatch repair proficient HNPCC families (MSS-HNPCC).
Garre P; Briceño V; Xicola RM; Doyle BJ; de la Hoya M; Sanz J; Llovet P; Pescador P; Puente J; Díaz-Rubio E; Llor X; Caldés T
Clin Cancer Res; 2011 Apr; 17(7):1701-12. PubMed ID: 21355073
[TBL] [Abstract][Full Text] [Related]
48. DNA damage, superoxide, and mutant K-ras in human lung adenocarcinoma cells.
Romanowska M; Maciag A; Smith AL; Fields JR; Fornwald LW; Kikawa KD; Kasprzak KS; Anderson LM
Free Radic Biol Med; 2007 Oct; 43(8):1145-55. PubMed ID: 17854710
[TBL] [Abstract][Full Text] [Related]
49. Oxidative damage to purines in DNA: role of mammalian Ogg1.
Klungland A; Bjelland S
DNA Repair (Amst); 2007 Apr; 6(4):481-8. PubMed ID: 17127104
[TBL] [Abstract][Full Text] [Related]
50. MutYH (MYH) and colorectal cancer.
Sampson JR; Jones S; Dolwani S; Cheadle JP
Biochem Soc Trans; 2005 Aug; 33(Pt 4):679-83. PubMed ID: 16042573
[TBL] [Abstract][Full Text] [Related]
51. The peroxisome proliferator WY-14,643 promotes hepatocarcinogenesis caused by endogenously generated oxidative DNA base modifications in repair-deficient Csbm/m/Ogg1-/- mice.
Trapp C; Schwarz M; Epe B
Cancer Res; 2007 Jun; 67(11):5156-61. PubMed ID: 17545594
[TBL] [Abstract][Full Text] [Related]
52. An Msh2 point mutation uncouples DNA mismatch repair and apoptosis.
Lin DP; Wang Y; Scherer SJ; Clark AB; Yang K; Avdievich E; Jin B; Werling U; Parris T; Kurihara N; Umar A; Kucherlapati R; Lipkin M; Kunkel TA; Edelmann W
Cancer Res; 2004 Jan; 64(2):517-22. PubMed ID: 14744764
[TBL] [Abstract][Full Text] [Related]
53. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis.
Mills NE; Fishman CL; Scholes J; Anderson SE; Rom WN; Jacobson DR
J Natl Cancer Inst; 1995 Jul; 87(14):1056-60. PubMed ID: 7616596
[TBL] [Abstract][Full Text] [Related]
54. Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene.
Lin L; Festing MF; Devereux TR; Crist KA; Christiansen SC; Wang Y; Yang A; Svenson K; Paigen B; Malkinson AM; You M
Exp Lung Res; 1998; 24(4):481-97. PubMed ID: 9659579
[TBL] [Abstract][Full Text] [Related]
55. Isolation and analyses of MutY homologs (MYH).
Lu-Chang AL
Methods Enzymol; 2006; 408():64-78. PubMed ID: 16793363
[TBL] [Abstract][Full Text] [Related]
56. Predominant K-ras codon 12 G --> A transition in chemically induced lung neoplasms in B6C3F1 mice.
Ton TV; Hong HH; Anna CH; Dunnick JK; Devereux TR; Sills RC; Kim Y
Toxicol Pathol; 2004; 32(1):16-21. PubMed ID: 14713543
[TBL] [Abstract][Full Text] [Related]
57. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
[TBL] [Abstract][Full Text] [Related]
58. K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases.
Cuatrecasas M; Villanueva A; Matias-Guiu X; Prat J
Cancer; 1997 Apr; 79(8):1581-6. PubMed ID: 9118042
[TBL] [Abstract][Full Text] [Related]
59. K-ras cancer gene mutations in lung tumors from female Swiss (CD-1) mice exposed transplacentally to 3'-azido-3'-deoxythymidine.
Koujitani T; Ton TV; Lahousse SA; Hong HH; Wakamatsu N; Sills RC
Environ Mol Mutagen; 2008 Dec; 49(9):720-6. PubMed ID: 18800350
[TBL] [Abstract][Full Text] [Related]
60. K-ras and rho A mutations in malignant pleural effusion.
Nakamoto M; Teramoto H; Matsumoto S; Igishi T; Shimizu E
Int J Oncol; 2001 Nov; 19(5):971-6. PubMed ID: 11604996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
